The ethics behind the world’s most expensive medication
With the recent FDA approval, Zolgensma became the world’s most expensive medication. Priced at $2.125 million per patient, the one-dose gene therapy is a potential life-saver for children with spinal muscular atrophy (SMA). Now, the treatment is at the center of an intensifying debate over the rising price of medications. Industry watchdogs are outraged. They say Zolgensma
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed